Brainsway Ltd.
BWAYNasdaq
$15.73
↑ +6.0%Jul 17 close · end-of-day
Price
1Y↑ +158.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry.
- CEO
- Christopher R. von Jako
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 120
- Website
- brainsway.com
Management & directors
- Moiseyev GiladChief Technology Officer
- Roth YiftachChief Scientist
Roles derived from SEC Form 4 filings.
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Jul 16, 2026
Jul 14, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-15 | Moiseyev Gilad· Chief Technology Officer | Sale | 5,000 | — | — | filing |
| 2026-06-02 | Roth Yiftach· Chief Scientist | Sale | 1,000 | — | — | filing |
| 2026-06-02 | Roth Yiftach· Chief Scientist | Sale | 2,000 | — | — | filing |
| 2026-06-01 | Roth Yiftach· Chief Scientist | Sale | 2,000 | — | — | filing |
| 2026-06-01 | Roth Yiftach· Chief Scientist | Sale | 2,000 | — | — | filing |
| 2026-05-26 | Mitrany Rayten Michal Ety | Sale | 7,980 | — | — | filing |
| 2026-05-25 | Moiseyev Gilad· Chief Technology Officer | Option exercise | 7,500 | — | — | filing |
| 2026-05-25 | Moiseyev Gilad· Chief Technology Officer | Tax withholding | 1,902 | — | — | filing |
| 2026-05-25 | Mitrany Rayten Michal Ety | Sale | 10,000 | — | — | filing |
| 2026-05-20 | Mitrany Rayten Michal Ety | Option exercise | 17,500 | — | — | filing |
| 2026-05-20 | Mitrany Rayten Michal Ety | Tax withholding | 6,080 | — | — | filing |
| 2026-05-19 | Mitrany Rayten Michal Ety | Option exercise | 10,000 | — | — | filing |
| 2026-05-19 | Mitrany Rayten Michal Ety | Tax withholding | 3,440 | — | — | filing |
Latest 13 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.